Anabolic androgenic steroid induced myocardial toxicity: An evolving problem in an ageing population

BMJ Case Reports

Volumn , Issue , 2011, Pages

  Rothman, Richard D ^a   Weiner, Rory B ^a   Pope, Harrison ^b   Kanayama, Gen ^b   Hutter Jr , Adolph M ^a   Fifer, Michael A ^a   Dec Jr , G William ^a   Baggish, Aaron L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; FUROSEMIDE; LISINOPRIL; METANDIENONE; NADROLONE; UNCLASSIFIED DRUG; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; CARDIOTOXICITY; CARDIOVASCULAR FUNCTION; CASE REPORT; DIASTOLIC DYSFUNCTION; DRUG DEPENDENCE; DRUG WITHDRAWAL; DYSPNEA; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FOLLOW UP; HEART FAILURE; HEPATOMEGALY; HUMAN; HYPOKINESIA; MALE; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; TRAINING; TREATMENT RESPONSE; CARDIOMYOPATHIES; CHEMICALLY INDUCED; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; MIDDLE AGED;

ANABOLIC AGENTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; DIURETICS; ECHOCARDIOGRAPHY, DOPPLER; FUROSEMIDE; HUMANS; LISINOPRIL; MALE; MIDDLE AGED;

EID: 80053069550     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.05.2011.4280     Document Type: Article

References (12)

1. Urhausen A, Albers T, Kindermann W. Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart 2004;90:496-501. (Pubitemid 38530163)
2. Pesola MK. Reversibility of the haemodynamic effects of anabolic steroids in rats. Eur J Appl Physiol Occup Physiol 1988;58:125-31.
3. Grace FM, Davies B. Raised concentrations of C reactive protein in anabolic steroid using bodybuilders. Br J Sports Med 2004;38:97-8. (Pubitemid 38183615)
4. Nieminen MS, Rämö MP, Viitasalo M, et al. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J 1996;17:1576-83. (Pubitemid 26345149)
5. Hurley BF, Seals DR, Hagberg JM, et al. High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use. JAMA 1984;252:507-13. (Pubitemid 14088104)
6. Alves MJ, Dos Santos MR, Dias RG, et al. A bnormal neurovascular control in anabolic androgenic steroids users. Med Sci Sports Exerc 2010;42:865-71.
7. Baggish AL, W einer RB, Kanayama G, et al. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail 2010;3:472-6.
8. Fanton L, Belhani D, Vaillant F, et al. Heart lesions associated with anabolic steroid abuse: comparison of post-mortem fi ndings in athletes and norethandrolone-induced lesions in rabbits. Exp Toxicol Pathol 2009;61:317-23.
9. Huie MJ. An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sports Exerc 1994;26:408-13. (Pubitemid 24116556)
10. Hausmann R, Hammer S, Betz P. Performance enhancing drugs (doping agents) and sudden death - a case report and review of the literature. Int J Legal Med 1998;111:261-4. (Pubitemid 28381427)
11. McCarthy K, T ang AT, Dalrymple-Hay MJ, et al. Ventricular thrombosis and systemic embolism in bodybuilders: etiology and management. Ann Thorac Surg 2000;70:658-60.
12. Ahlgrim C, Guglin M. Anabolics and cardiomyopathy in a bodybuilder: case report and literature review. J Card Fail 2009;15:496-500.